Back to Search
Start Over
Towards understandings of serine/arginine-rich splicing factors.
- Source :
- Acta Pharmaceutica Sinica B; Aug2023, Vol. 13 Issue 8, p3181-3207, 27p
- Publication Year :
- 2023
-
Abstract
- Serine/arginine-rich splicing factors (SRSFs) refer to twelve RNA-binding proteins which regulate splice site recognition and spliceosome assembly during precursor messenger RNA splicing. SRSFs also participate in other RNA metabolic events, such as transcription, translation and nonsense-mediated decay, during their shuttling between nucleus and cytoplasm, making them indispensable for genome diversity and cellular activity. Of note, aberrant SRSF expression and/or mutations elicit fallacies in gene splicing, leading to the generation of pathogenic gene and protein isoforms, which highlights the therapeutic potential of targeting SRSF to treat diseases. In this review, we updated current understanding of SRSF structures and functions in RNA metabolism. Next, we analyzed SRSF-induced aberrant gene expression and their pathogenic outcomes in cancers and non-tumor diseases. The development of some well-characterized SRSF inhibitors was discussed in detail. We hope this review will contribute to future studies of SRSF functions and drug development targeting SRSFs. This review summarizes the current understandings of serine/arginine-rich splicing factors (SRSFs) with an emphasis on their structures, functions, pathological implications and small molecule modulators of SRSFs. [Display omitted] [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 22113835
- Volume :
- 13
- Issue :
- 8
- Database :
- Supplemental Index
- Journal :
- Acta Pharmaceutica Sinica B
- Publication Type :
- Academic Journal
- Accession number :
- 170024541
- Full Text :
- https://doi.org/10.1016/j.apsb.2023.05.022